2021
Launched iFlash 1200 the smallest model of iFlash Family
IPO Listed on SSE (Shanghai Stock Exchange)
2020
Launched CLIA Assays for SARS-CoV-2
2019
Launched iModules Modular System
Awarded “Top Innovative Enterprises in Shenzhen”
Won the prize of “Innovation Star Cup for Excellent Reagent”
2018
Awarded “Enterprise with Intellectual Property Advantages”
Launched VISION Pro, the ESR analyzer
Headquarters moved in YHLO Biopark
2017
Launched iFlash 1800 (Bench-top CLIA) and UNICELL POCT System
Awarded “China Most Investment Valuable Brand in IVD Field”
Dr. Frank, YHLO’s chief scientist—— “Lifetime Honorary Award of China IVD Industry Leader”
Inhibin B won the first prize of “Innovative Star Cup”
2016
Launched iFlash 3000, China’s first high throughput CLIA analyzer
Received Europe/US patents for VISION
AMH won the third prize of “Innovative Star Cup”
2010
Received ISO 9001 certificate
Awarded “Shenzhen High-Tech Enterprise”
2009
Launched autoimmune assays
Established Europe R&D office
2008
Established YHLO Biotech, specialized in immunoassay
2002
Distribution of IVD products through the trading company